Displaying drugs 1 - 25 of 153 in total
PF-04418948
Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers).
Investigational
Matched Name: … PF-04418948 …
Matched Description: … Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers). ... Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And …
Matched Description: … Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers). ... Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And …
PF-06815345
PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in Healthy Subjects).
Investigational
Matched Name: … PF-06815345 …
Matched Description: … PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in …
Matched Description: … PF-06815345 is under investigation in clinical trial NCT02654899 (Single Dose Study of PF-06815345 in …
PF-5190457
PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations In Healthy Volunteers).
Investigational
Matched Name: … PF-5190457 …
Matched Description: … PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations …
Matched Description: … PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations …
PF-04620110
PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).
Investigational
Matched Name: … PF-04620110 …
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 …
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 …
PF-04634817
PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects).
Investigational
Matched Name: … PF-04634817 …
Matched Description: … Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects). ... PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine …
Matched Description: … Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects). ... PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine …
PF-06700841
PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers).
Investigational
Matched Name: … PF-06700841 …
Matched Description: … PF-06700841 in Japanese Healthy Volunteers). ... PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of …
Matched Description: … PF-06700841 in Japanese Healthy Volunteers). ... PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of …
PF-05105679
PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).
Investigational
Matched Name: … PF-05105679 …
Matched Description: … Volunteers Study Of PF-05105679). ... PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy …
Matched Description: … Volunteers Study Of PF-05105679). ... PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy …
PF-04995274
Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274).
Investigational
Matched Name: … PF-04995274 …
Matched Description: … Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate ... The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274 …
Matched Description: … Pf 04995274 is under investigation in clinical trial NCT01193062 (Study In Healthy Subjects To Evaluate ... The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274 …
PF-05212377
PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms on Donepezil).
Investigational
Matched Name: … PF-05212377 …
Matched Description: … PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy ... of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms …
Matched Description: … PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy ... of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms …
PF-03758309
PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Investigational
Matched Name: … PF-03758309 …
Matched Description: … PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors. …
Matched Salts name: … Pf 03758309 Hydrochloride …
Matched Description: … PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors. …
Matched Salts name: … Pf 03758309 Hydrochloride …
PF-00446687
PF-00446687 has been investigated for the treatment of Erectile Dysfunction.
Investigational
Matched Name: … PF-00446687 …
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
Matched Description: … PF-00446687 has been investigated for the treatment of Erectile Dysfunction. …
PF-477736
PF-00477736 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Name: … PF-477736 …
Matched Description: … PF-00477736 has been used in trials studying the treatment of Neoplasms. …
Matched Description: … PF-00477736 has been used in trials studying the treatment of Neoplasms. …
PF-04217903
PF-04217903 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Name: … PF-04217903 …
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
PF-03814735
PF-03814735 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Name: … PF-03814735 …
Matched Description: … PF-03814735 has been used in trials studying the treatment of Solid Tumors. …
Matched Description: … PF-03814735 has been used in trials studying the treatment of Solid Tumors. …
PF-00489791
PF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic Nephropathies, Hypertension, Pulmonary, and Peripheral Vascular Disease.
Investigational
Matched Name: … PF-00489791 …
Matched Description: … PF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic …
Matched Description: … PF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic …
PF-03715455
PF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive, and Chronic Obstructive Pulmonary Disease (COPD).
Investigational
Matched Name: … PF-03715455 …
Matched Description: … PF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive …
Matched Description: … PF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive …
PF-03382792
Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers).
Investigational
Matched Name: … PF-03382792 …
Matched Description: … Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma …
Matched Description: … Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma …
PF-06459988
PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer).
Investigational
Matched Name: … PF-06459988 …
Matched Description: … PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal …
Matched Description: … PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal …
PF-03187207
PF-03187207 is a nitric oxide-donating prostaglandin F2-alpha analogs for the potential treatment of glaucoma. Based on the very promising preclinical results and on the well-known activities of nitric oxide, PF-03187207 is expected to have an increased capacity to reduce high IOP. The development of abnormally high IOP, due to blockage...
Investigational
Matched Name: … PF-03187207 …
Matched Description: … PF-03187207 is a nitric oxide-donating prostaglandin F2-alpha analogs for the potential treatment of ... Based on the very promising preclinical results and on the well-known activities of nitric oxide, PF- …
Matched Description: … PF-03187207 is a nitric oxide-donating prostaglandin F2-alpha analogs for the potential treatment of ... Based on the very promising preclinical results and on the well-known activities of nitric oxide, PF- …
PF-232798
PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects).
Investigational
Matched Synonyms: … PF-00232798 …
Matched Name: … PF-232798 …
Matched Description: … Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects). ... PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple …
Matched Name: … PF-232798 …
Matched Description: … Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects). ... PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple …
PF-07304814
PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro), which is used by viruses like SARS-CoV-2 to assemble and multiply . Once administered through intravenous infusion, the compound is cleaved into PF-00835231 to exert its anti-viral effects . PF-07304814, developed by Pfizer, was first identified during the...
Investigational
Matched Name: … PF-07304814 …
Matched Description: … PF-07304814, developed by Pfizer, was first identified during the SARS outbreak in 2002-2003; it was ... PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro) ... Once administered through intravenous infusion, the compound is cleaved into PF-00835231 to exert its …
Matched Description: … PF-07304814, developed by Pfizer, was first identified during the SARS outbreak in 2002-2003; it was ... PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro) ... Once administered through intravenous infusion, the compound is cleaved into PF-00835231 to exert its …
PF-06305591
Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple Doses of PF-06305591).
Investigational
Matched Name: … PF-06305591 …
Matched Description: … Doses of PF-06305591). ... Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple …
Matched Description: … Doses of PF-06305591). ... Pf 06305591 is under investigation in clinical trial NCT01776619 (Safety and Tolerability Study of Multiple …
PF-04457845
PF-04457845 is under investigation in Fear Conditioning. PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence.
Investigational
Matched Name: … PF-04457845 …
Matched Description: … PF-04457845 is under investigation in Fear Conditioning. ... PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence. …
Matched Description: … PF-04457845 is under investigation in Fear Conditioning. ... PF-04457845 has been investigated for the treatment of Tourette Syndrome and Cannabis Dependence. …
Displaying drugs 1 - 25 of 153 in total